Page last updated: 2024-09-03

3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid and sulfinpyrazone

3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid has been researched along with sulfinpyrazone in 1 studies

Compound Research Comparison

Studies
(3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid)
Trials
(3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid)
Recent Studies (post-2010)
(3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid)
Studies
(sulfinpyrazone)
Trials
(sulfinpyrazone)
Recent Studies (post-2010) (sulfinpyrazone)
36111,12217232

Protein Interaction Comparison

ProteinTaxonomy3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid (IC50)sulfinpyrazone (IC50)
fMet-Leu-Phe receptorHomo sapiens (human)14.4
fMet-Leu-Phe receptorHomo sapiens (human)10

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ambler, J; Butler, KD; Butler, PA; Shand, RA; Wallis, RB1

Other Studies

1 other study(ies) available for 3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid and sulfinpyrazone

ArticleYear
Prolongation of platelet survival in hypercholesterolaemic rabbits by CGS 12970 (3-methyl-2-(3-pyridyl)-1 indoleoctanoic acid) and dazoxiben.
    Thrombosis research, 1987, Mar-15, Volume: 45, Issue:6

    Topics: Animals; Aspirin; Blood Platelets; Cell Survival; Cholesterol, Dietary; Cyclooxygenase Inhibitors; Hypercholesterolemia; Imidazoles; Pyridines; Rabbits; Sulfinpyrazone; Thromboxane B2; Thromboxane-A Synthase

1987